Video
UTI incidence is low among infants who have spina bifida
Author(s):
“For now, the UMPIRE [study] protocol will continue to withhold prophylaxis in the newborn population,” says investigator M. Chad Wallis, MD, FACS.
Video Player is loading.
In this video, M. Chad Wallis, MD, FACS, discusses the recent Journal of Urology paper, “Incidence of Urinary Tract Infections in Newborns with Spina Bifida: Is Antibiotic Prophylaxis Necessary?, for which he served as a study author. Wallis is a clinical associate professor of surgery in the division of urology at the University of Utah in Salt Lake City.
Related Videos
Urologist discusses drug cost savings, price transparency
Neeraj Agarwal, MD, shares key takeaways from TALAPRO-2
Expert describes implications of neoadjuvant durvalumab approval in MIBC
Ian Metzler, MD, highlights recent advances in kidney stone technology
Ekene Enemchukwu, MD, on underutilization of vaginal estrogen for GSM
Sima Porten, MD, on gene-environment interactions in bladder cancer development
Naeem Bhojani, MD, expands on key findings from WATER III trial
Hailey Frye discusses improvement of pain management for nephrolithiasis
Ekene Enemchukwu, MD, on trends in vaginal estrogen use for GSM
How rBCG EAP could open up access for Anktiva in bladder cancer
Related Content
